Goldman Sachs Group Inc. Purchases 531,996 Shares of Medical Properties Trust, Inc. (NYSE:MPW)

Goldman Sachs Group Inc. boosted its position in shares of Medical Properties Trust, Inc. (NYSE:MPW) by 34.9% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 2,055,343 shares of the real estate investment trust’s stock after acquiring an additional 531,996 shares during the period. Goldman Sachs Group Inc. owned 0.40% of Medical Properties Trust worth $43,389,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in MPW. Marshall Wace LLP bought a new stake in Medical Properties Trust during the 1st quarter worth approximately $148,000. Voya Investment Management LLC raised its stake in Medical Properties Trust by 94.2% during the 3rd quarter. Voya Investment Management LLC now owns 134,769 shares of the real estate investment trust’s stock worth $2,636,000 after acquiring an additional 65,373 shares during the period. Redpoint Investment Management Pty Ltd raised its stake in Medical Properties Trust by 12.3% during the 3rd quarter. Redpoint Investment Management Pty Ltd now owns 44,141 shares of the real estate investment trust’s stock worth $863,000 after acquiring an additional 4,840 shares during the period. New Mexico Educational Retirement Board raised its stake in Medical Properties Trust by 15.3% during the 3rd quarter. New Mexico Educational Retirement Board now owns 76,000 shares of the real estate investment trust’s stock worth $1,487,000 after acquiring an additional 10,100 shares during the period. Finally, State Street Corp raised its stake in Medical Properties Trust by 12.2% during the 3rd quarter. State Street Corp now owns 18,621,664 shares of the real estate investment trust’s stock worth $369,012,000 after acquiring an additional 2,030,387 shares during the period. Institutional investors own 84.22% of the company’s stock.

Medical Properties Trust stock opened at $15.93 on Thursday. The stock has a market cap of $7.41 billion, a P/E ratio of 18.52, a PEG ratio of 1.55 and a beta of 0.62. The company has a debt-to-equity ratio of 1.00, a current ratio of 9.45 and a quick ratio of 9.45. Medical Properties Trust, Inc. has a 1 year low of $12.35 and a 1 year high of $24.29. The firm’s 50 day moving average price is $20.85 and its 200-day moving average price is $20.55.

Medical Properties Trust (NYSE:MPW) last released its quarterly earnings data on Thursday, February 6th. The real estate investment trust reported $0.26 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.35 by ($0.09). The company had revenue of $256.44 million for the quarter, compared to the consensus estimate of $263.35 million. Medical Properties Trust had a net margin of 43.86% and a return on equity of 6.57%. The company’s quarterly revenue was up 42.0% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.31 EPS. As a group, equities analysts expect that Medical Properties Trust, Inc. will post 1.65 EPS for the current year.

The firm also recently declared a quarterly dividend, which will be paid on Thursday, April 9th. Investors of record on Thursday, March 12th will be given a $0.27 dividend. This represents a $1.08 annualized dividend and a yield of 6.78%. The ex-dividend date is Wednesday, March 11th. This is a boost from Medical Properties Trust’s previous quarterly dividend of $0.26. Medical Properties Trust’s payout ratio is currently 83.08%.

A number of equities research analysts have commented on the stock. Bank of America upgraded shares of Medical Properties Trust from a “neutral” rating to a “buy” rating in a research note on Monday. Zacks Investment Research cut shares of Medical Properties Trust from a “buy” rating to a “hold” rating in a research note on Wednesday, March 11th. KeyCorp lifted their price objective on shares of Medical Properties Trust from $22.00 to $23.00 and gave the company an “overweight” rating in a research report on Thursday, January 16th. TheStreet upgraded shares of Medical Properties Trust from a “c+” rating to a “b” rating in a research report on Thursday, February 6th. Finally, Robert W. Baird lifted their price objective on shares of Medical Properties Trust from $20.00 to $22.00 and gave the company a “neutral” rating in a research report on Tuesday, January 14th. Three research analysts have rated the stock with a hold rating and ten have given a buy rating to the company. The company presently has a consensus rating of “Buy” and a consensus price target of $21.88.

In related news, COO Emmett E. Mclean sold 100,000 shares of the business’s stock in a transaction on Wednesday, January 8th. The shares were sold at an average price of $20.84, for a total value of $2,084,000.00. Following the sale, the chief operating officer now owns 1,003,415 shares in the company, valued at $20,911,168.60. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Insiders own 1.18% of the company’s stock.

Medical Properties Trust Profile

Medical Properties Trust, Inc is a self-advised real estate investment trust formed to capitalize on the changing trends in healthcare delivery by acquiring and developing net-leased healthcare facilities. MPT's financing model helps facilitate acquisitions and recapitalizations and allows operators of hospitals and other healthcare facilities to unlock the value of their real estate assets to fund facility improvements, technology upgrades and other investments in operations.

See Also: Channel Trading

Institutional Ownership by Quarter for Medical Properties Trust (NYSE:MPW)

Receive News & Ratings for Medical Properties Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medical Properties Trust and related companies with MarketBeat.com's FREE daily email newsletter.